Published in Surgery on February 08, 2010
Postoperative burden of hospital-acquired Clostridium difficile infection. Infect Control Hosp Epidemiol (2015) 0.83
The simple predictors of pseudomembranous colitis in patients with hospital-acquired diarrhea: a prospective observational study. Gut Liver (2013) 0.81
Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach. BMC Infect Dis (2016) 0.78
Excess risk of Clostridium difficile infection in ovarian cancer is related to exposure to broad-spectrum antibiotics. Support Care Cancer (2013) 0.77
Very mild dementia and medical comorbidity independently predict health care use in the elderly. J Prim Care Community Health (2011) 0.77
Antibiotic prophylaxis for surgical site infections as a risk factor for infection with Clostridium difficile. PLoS One (2017) 0.75
The role of single-shot metronidazole in the prevention of Clostridium difficile infection following ileostomy reversal surgery. Int J Colorectal Dis (2016) 0.75
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol (1992) 60.45
Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med (1998) 32.43
Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA (2005) 6.87
Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ (2005) 5.59
Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg Infect Dis (2007) 4.61
Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet (2001) 4.59
Estimating treatment effects using observational data. JAMA (2007) 4.12
Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis (2008) 3.88
Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001. J Infect Dis (2004) 3.42
Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy. CMAJ (2006) 3.18
Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg (2007) 2.55
Preoperative oral antibiotics reduce septic complications of colon operations: results of prospective, randomized, double-blind clinical study. Ann Surg (1977) 2.36
Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother (2001) 2.35
Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients. Am J Gastroenterol (2008) 2.32
Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol (2007) 2.20
Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982. J Infect Dis (1985) 2.16
Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol (2002) 1.94
A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile Study Group. Clin Infect Dis (1998) 1.84
Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients. Emerg Infect Dis (2008) 1.67
Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding. Ann Intern Med (1998) 1.39
Preoperative oral antibiotics in colorectal surgery increase the rate of Clostridium difficile colitis. Arch Surg (2005) 1.33
Hospital-acquired Clostridium difficile-associated disease in the intensive care unit setting: epidemiology, clinical course and outcome. BMC Infect Dis (2007) 1.22
Epidemiology and molecular characterization of Clostridium difficile strains from patients with diarrhea: low disease incidence and evidence of limited cross-infection in a Swedish teaching hospital. J Clin Microbiol (2003) 1.22
Oral versus systemic antibiotic prophylaxis in elective colon surgery: a randomized study and meta-analysis send a message from the 1990s. Can J Surg (2002) 1.16
Clostridium difficile diarrhea induced by cancer chemotherapy. Arch Intern Med (1992) 1.15
Disease associated with Clostridium difficile infection. Ann Intern Med (1989) 1.12
Stress-related mucosal disease: risk factors and prophylactic therapy. Clin Ther (2004) 1.02
Epidemiology and incidence of Clostridium difficile-associated diarrhoea diagnosed upon admission to a university hospital. J Hosp Infect (2006) 1.00
Clostridium difficile colitis after kidney and kidney-pancreas transplantation. Clin Transplant (1999) 0.96
The impact of Clostridium difficile on a surgical service: a prospective study of 374 patients. Ann Surg (1998) 0.91
Clostridium difficile in cardiac surgery: risk factors and impact on postoperative outcome. Ann Thorac Surg (2007) 0.90
Diarrhea and Clostridium difficile-associated diarrhea on a surgical service. Arch Surg (1996) 0.86
Clostridium difficile infection: a surgical disease in evolution. J Gastrointest Surg (2008) 0.86
Duration of postoperative immunosuppression assessed by repeated delayed type hypersensitivity skin tests. Eur Surg Res (1992) 0.82
Stress ulcers are common after aortic surgery. Endoscopic evaluation of prophylactic therapy. Am Surg (1994) 0.80
Antibiotic prophylaxis and the risk of Clostridium difficile-associated diarrhoea. J Hosp Infect (2001) 0.80
Cefuroxime versus ceftriaxone prophylaxis in cardiovascular surgery. Drugs Exp Clin Res (1985) 0.79
Clostridium difficile colitis after aortic surgery. Eur J Vasc Endovasc Surg (1997) 0.77
Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol (2013) 7.81
An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol (2009) 3.99
Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol (2011) 3.81
Treatment of refractory/recurrent C. difficile-associated disease by donated stool transplanted via colonoscopy: a case series of 12 patients. J Clin Gastroenterol (2010) 1.88
Mesenteric venous thrombosis. Vasc Med (2010) 1.71
Longer lengths of stay and higher risk of mortality among inpatients of physicians with more years in practice. Am J Med (2011) 1.70
Fecal microbiota transplantation: past, present and future. Curr Opin Gastroenterol (2013) 1.59
Ismar Boas: father of gastroenterology and founder of the oldest surviving publication in digestive diseases. Am J Gastroenterol (2011) 1.57
Clostridium difficile infection and inflammatory bowel disease. J Clin Gastroenterol (2013) 1.57
Ischemic colitis has a worse prognosis when isolated to the right side of the colon. Am J Gastroenterol (2007) 1.45
Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol (2009) 1.39
Clinical patterns and outcomes of ischaemic colitis: results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE study). Scand J Gastroenterol (2010) 1.33
Recommendations for probiotic use-2011 update. J Clin Gastroenterol (2011) 1.19
Colon ischemia: recent insights and advances. Curr Gastroenterol Rep (2010) 1.11
The FDA's decision-making process: isn't it time to temper the principle of protective paternalism? Am J Gastroenterol (2008) 1.10
Editorial commentary: fecal microbiota transplantation: patient and physician attitudes. Clin Infect Dis (2012) 1.08
Intestinal ischemia. Gastroenterol Clin North Am (2003) 1.07
The intestinal microbiota and obesity. J Clin Gastroenterol (2012) 1.06
Glucocorticoids are associated with increased risk of short-term mortality in hospitalized patients with clostridium difficile-associated disease. Am J Gastroenterol (2010) 1.06
Diverticular disease of the colon does not increase risk of repeat C. difficile infection. J Clin Gastroenterol (2013) 1.04
Endoscopic fecal microbiota transplantation: "first-line" treatment for severe clostridium difficile infection? J Clin Gastroenterol (2011) 0.99
Report of the multisociety task force on GI training. Gastroenterology (2009) 0.96
Long-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile Infection: A Multicenter Experience. J Clin Gastroenterol (2016) 0.93
Report of the Multisociety Task Force on GI training. Gastrointest Endosc (2009) 0.93
The Long-term Efficacy and Safety of Fecal Microbiota Transplant for Recurrent, Severe, and Complicated Clostridium difficile Infection in 146 Elderly Individuals. J Clin Gastroenterol (2016) 0.92
Therapeutic faecal microbiota transplantation: current status and future developments. Curr Opin Gastroenterol (2014) 0.92
Pharmacologically mediated colon ischemia. Am J Gastroenterol (2007) 0.90
Recommendations for Probiotic Use-2015 Update: Proceedings and Consensus Opinion. J Clin Gastroenterol (2015) 0.89
Recurrence patterns after first resection for stricturing or penetrating Crohn's disease. Inflamm Bowel Dis (2009) 0.88
Fecal microbiota transplantation: a new standard treatment option for Clostridium difficile infection. Expert Rev Anti Infect Ther (2013) 0.87
Association between tree pollen counts and asthma ED visits in a high-density urban center. J Asthma (2011) 0.87
The impact of ethnicity and obesity on the course of colonic diverticulitis. J Clin Gastroenterol (2013) 0.86
On the role of ischemia in the pathogenesis of IBD: a review. Inflamm Bowel Dis (2010) 0.85
Bone, inflammation, and inflammatory bowel disease. Curr Osteoporos Rep (2011) 0.83
Indications for image-guidance in pediatric sinonasal surgery. Int J Pediatr Otorhinolaryngol (2009) 0.81
Pulse transit time by R-wave-gated infrared photoplethysmography: review of the literature and personal experience. J Clin Monit Comput (2004) 0.81
Report of the Multisociety Task Force on GI training. Hepatology (2009) 0.80
Pharmacologic management of mesenteric occlusive disease. Cardiol Rev (2008) 0.79
FMT: first step in a long journey. Am J Gastroenterol (2013) 0.78
Flexible sigmoidoscopy: the patients' perception. Gastrointest Endosc (2002) 0.78
Deformation of the anus: an alternative to rectal air suctioning for patient comfort after colonoscopy. Gastrointest Endosc (2004) 0.77
Hepatoportal sclerosis (obliterative portal venopathy) and nodular regenerative hyperplasia in a patient with myasthenia gravis: A case report and review of the published work. Hepatol Res (2013) 0.76
Drug therapies for mesenteric vascular disease. Heart Dis (2002) 0.76
Segmental increases in force application during colonoscope insertion: quantitative analysis using force monitoring technology. Gastrointest Endosc (2012) 0.75
Ischemic colitis complicating aortic dissection. Gastrointest Endosc (2002) 0.75
The lament of the chief complaint: not one, not always, but a good conversational start. Am J Gastroenterol (2007) 0.75
Chronic mesenteric ischemia and visible light spectroscopy: can a dark path be illuminated? Gastrointest Endosc (2006) 0.75
Endoscopic ultrasound-fine needle aspiration: A novel way to diagnose a solitary extramedullary plasmacytoma of the liver. Endosc Ultrasound (2016) 0.75
The American College of Gastroenterology irritable bowel syndrome monograph: translating systematic review data to clinical practice. Gastroenterology (2009) 0.75
Acid-related disorders from pediatrics to geriatrics: reducing risks and optimizing outcomes. Am J Med (2004) 0.75
Pseudolipomatosis polyposis. Gastrointest Endosc (2006) 0.75
Postinfection Irritable Bowel Syndrome: The Links Between Gastroenteritis, Inflammation, the Microbiome, and Functional Disease. J Clin Gastroenterol (2017) 0.75